You are here

  • Home
  • Archive
  • Volume 10, Issue 12
  • Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19+ malignancy

Article metrics

Article menu

Download PDFPDF

Immune cell therapies and immune cell engineering
Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19+ malignancy

 

Online download statistics by month:

Online download statistics by month: December 2022 to January 2026

AbstractFullPdf
Dec 2022685693263
Jan 202327427593
Feb 202316416549
Mar 20239910347
Apr 2023777938
May 2023808234
Jun 2023808142
Jul 2023656525
Aug 2023585925
Sep 2023545640
Oct 2023798131
Nov 2023757820
Dec 2023454826
Jan 2024697041
Feb 2024525326
Mar 20246262138
Apr 2024434430
May 2024717430
Jun 2024596024
Jul 2024707021
Aug 2024434219
Sep 2024333327
Oct 2024515025
Nov 2024667032
Dec 20246710826
Jan 2025434522
Feb 2025414118
Mar 2025282824
Apr 2025757537
May 2025515139
Jun 2025454616
Jul 2025220
Sep 2025550
Jan 2026001
Total281128941329